Vistin Pharma ASA : Key information relating to the cash dividend to be paid by Vistin Pharma ASA
Dividend amount: NOK 0.5 Declared currency: NOK Last day including right: 20 May 2021 Ex-date: 21 May 2021 Record date:...
News
Illingworth Research Group Recognized with Queen’s Award for Enterprise: International Trade 2021
MORRISVILLE, N.C., April 30, 2021 (GLOBE NEWSWIRE) -- The Illingworth Research Group, a Syneos Health® company, has been recognized with...
PCI Biotech: Invitation to first quarter 2021 results presentation
Oslo, Norway, 30 April 2021 - PCI Biotech’s (OSE: PCIB) first quarter 2021 interim report will be released on 7...
Audited annual report 2020
New JSC Olainfarm strategy is approvedThe Company reviewed operations in the main marketsJSC Olainfarm continued investments to modernize its operations...
Conscience Project challenges Ontario College of Physicians policy
Policy that would force physicians out of Covid fight not in public interestPOWELL RIVER, British Columbia, April 30, 2021 (GLOBE...
Biophytis – Second Combined General Meeting to Take Place on May 10, 2021 without the physical presence of its shareholders
PARIS and CAMBRIDGE, Mass., April 30, 2021 (GLOBE NEWSWIRE) -- Biophytis SA (Euronext Growth Paris: ALBPS), a clinical-stage biotechnology company...
Change in numbers of shares and votes in Saniona AB (publ)
PRESS RELEASE April 30, 2021 During April, the registered number of shares and votes in Saniona AB (publ) (“Saniona”) has...
Synairgen announces data from Home Cohort of SG016 Phase II trial of inhaled interferon beta in COVID-19 patients and encouraging combined data for whole SG016 trial
Press release Synairgen plc(‘Synairgen’ or the ‘Company’) Synairgen announces data from Home Cohort of SG016 Phase II trial of inhaled...
Glycotope Announces Poster Presentations at the 2021 American Society of Clinical Oncology (ASCO) Virtual Annual Meeting
Glycotope Announces Poster Presentations at the 2021 American Society of Clinical Oncology (ASCO) Virtual Annual Meeting Berlin, Germany, April 30,...
Nicox Updates on Fera Pharmaceuticals’ Continuing Evaluation of Naproxcinod
Press ReleaseNicox Updates on Fera Pharmaceuticals’ Continuing Evaluation of NaproxcinodApril 30, 2021 – release at 7:30 am CET Sophia Antipolis,...
OXURION NV Presenting Scientific Data at ARVO 2021 Annual Meeting
Leuven, BE, Boston, MA, US – April 30st, 2021 – 7.30 AM CET – Oxurion NV (Euronext Brussels: OXUR) is...
miDiagnostics accelerates with launch of rapid COVID-19 PCR test product
miDiagnostics accelerates with launch of rapid COVID-19 PCR test product Additional funding of 58 million euro for transition to a...
Werewolf Therapeutics Announces Pricing of Upsized Initial Public Offering
CAMBRIDGE, Mass., April 29, 2021 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (NASDAQ: HOWL), an innovative biopharmaceutical company pioneering the development...
Appendix 4C Quarterly Activity Report
Mesoblast Operational and Financial Highlights for Quarter Ended March 31, 2021NEW YORK, April 29, 2021 (GLOBE NEWSWIRE) -- Mesoblast Limited...
COMPASS Pathways announces pricing of public offering
London, UK, 30 April 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company...
Remestemcel-L Reduces Mortality in Patients Less Than 65 Years Old With Moderate/Severe COVID-19 ARDS: Topline 60-Day Results From Randomized Controlled Trial
Remestemcel-L reduced mortality through 60 days in the pre-specified population under 65 years oldIn these patients the benefit was further...
The Aesthetic Meeting 2021 Features Guest Lecture from Whole Beauty® Institute
The Chicago-Based Team Will Share Knowledge on Board-Certified Dr. John Q. Cook’s Structural Mastopexy Breast Lift Technique in the SpringCHICAGO,...
Mesoblast Corporate Update
NEW YORK, April 29, 2021 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory...
Vaccitech Announces Pricing of Initial Public Offering
OXFORD, United Kingdom, April 29, 2021 (GLOBE NEWSWIRE) -- Vaccitech plc (“Vaccitech”) (Nasdaq: VACC), a clinical-stage biopharmaceutical company engaged in...
Early Warning Reports Issued Pursuant to National Instrument 62-103 in Connection with the Completion of Private Share Sales
TORONTO, April 29, 2021 (GLOBE NEWSWIRE) -- Jack Burnett, President and a director of Ramm Pharma Corp. ("Ramm" or, the...